Analyses / KO
Stable cash generator with premium valuation; income + defensive appeal outweighing growth headwinds.
A free account reveals KO's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Resilient earnings growth (11.5% EPS), fortress margins (27% net, 30% operating), 66% payout ratio sustainable, 3.1% dividend yield with 52-year streak, low beta (0.30) ideal for risk-averse portfolios, Warren Buffett's largest holding, margin expansion potential from scale.
▼ Bear Case
P/E 27x and forward 29.4x stretch fair value for 4% revenue growth, price-to-FCF 73x signals expensive capital efficiency, P/B 9.3x lofty vs peers, 3-year peak puts stock near resistance, macro slowdown risk to volume/pricing, insider sellers outnumber buyers 82 vs 69 (slight net sell).
Valuation
OVERVALUED — score 38/100
P/E 27x and fwd 29.4x are 40–60% above historical and S&P 500 average; price-to-FCF 73x is elevated; P/S 8x and P/B 9.3x also premium. Quality and dividend streak justify a premium, but 10–15% multiple compression could be warranted if earnings growth disappoints or rates stabilize higher.
Technical Levels
Support · $88.50 (Recent low (intraday)) · $85.50 (20-day MA (approx)) · $82.00 (200-day MA / 3-month support zone)
Resistance · $90.36 (Day high / immediate resistance) · $92.49 (52-week high) · $95.00 (Psychological / next breakout target)
RSI: Not provided in payload; unable to assess overbought/oversold condition.
Financial Health
Score 78/100. Strong liquidity (current 1.46, quick 1.14) and fortress margins (61% gross, 30% operating, 27% net) underpin financial health. Payout ratio 67% leaves room for dividend growth without stress. Debt levels and interest coverage not provided; confirm via full 10-K, but large-cap status and cash-generation profile imply sound leverage.
Catalysts
| Q3 2024 Earnings (expected late Oct / early Nov) | ~3–6 weeks | Key to validate margin expansion and volume trajectory; any miss on EPS or guidance could trigger 3–5% pullback given premium valuation. |
| Dividend Announcement / October Ex-Date | This month (ex-date mentioned in recent news as Sept 15) | High — any increase would support stock and reinforce dividend-aristocrat narrative; static or cut (unlikely) would undermine bull case. |
| Macro / Fed Rate Outlook | Ongoing | Lower rates favor KO (lower discount rate, higher multiple justifiable); rising rates risk multiple compression. |
| Currency Headwinds (international exposure) | Ongoing | Strong USD pressures foreign earnings; forex stabilization could unlock upside. |
Risk Flags
See KO's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock KO free →Recent News
- Coca-Cola Co's Dividend AnalysisYahoo
- 3 Dividend Stocks Baby Boomers Should Own for the Rest of Their LivesYahoo
- This Warren Buffett-Approved Investment Could Turn $300 a Month Into $1 MillionYahoo
- Own Coca-Cola by Sept. 15 to Qualify for the Oct. 1 Dividend. Is the Real Prize Holding Enough Shares for $1,000 in Yearly Passive Income?Yahoo
- Coca-Cola (KO) Ascends While Market Falls: Some Facts to NoteYahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full KO analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
KO FAQ
Is KO a buy right now?
Coca-Cola Co's current read is a Dividend / Value / Defensive setup with 68 confidence over a 6-12 months horizon. Valuation: OVERVALUED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is KO overvalued?
OVERVALUED (valuation score 38/100). P/E 27x and fwd 29.4x are 40–60% above historical and S&P 500 average; price-to-FCF 73x is elevated; P/S 8x and P/B 9.3x also premium. Quality and dividend streak justify a premium, but 10–15% multiple compression could be warranted if earnings growth disappoints or rates stabilize higher.
What are the risks of buying KO?
P/E 27x and forward 29.4x stretch fair value for 4% revenue growth, price-to-FCF 73x signals expensive capital efficiency, P/B 9.3x lofty vs peers, 3-year peak puts stock near resistance, macro slowdown risk to volume/pricing, insider sellers outnumber buyers 82 vs 69 (slight net sell).